------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0104
Expires: Sept. 30, 1998
Estimated average burden
hours per response ....... 0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
================================================================================
1. Name and Address of Reporting Person
Feinberg Stephen
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Cerberus Partners, L.P.
450 Third Avenue, 28th Floor
- --------------------------------------------------------------------------------
(Street)
New York New York 10022
- --------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)
6/30/98
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
================================================================================
4. Issuer Name and Ticker or Trading Symbol
Coram Healthcare Corporation - CRH
================================================================================
5 Relationship of Reporting Person to Issuer
(Check all applicable)
[ X ] Director [X**] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
--------------------------------------------------------------------
================================================================================
6. If Amendment, Date of Original (Month/Year)
================================================================================
7. Individual or Joint/Group Filing
(Check Applicable Line)
X* Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr.5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Security Exer- tion of Derivative (I) Ownership
(Instr. 4) cisable Date Title Shares Security (Instr.5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Series B Convertible Notes immed. 4/15/2008 Common Stock 13,488,238* $3.00 I* By partnerships
(right to buy) and corporations
- ------------------------------------------------------------------------------------------------------------------------------------
Warrants immed. 10/13/2000 Common Stock 191,273* .001 I* By partnerships
(right to buy) and corporations
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
* Cerberus Partners, L.P.. ("Cerberus") is the holder of an aggregate of
$22,412,956 principal amount of Series B Convertible Subordinated Notes due 2008
(the "Notes") of Coram Healthcare Corporation (the "Company"), which amount
includes $7,238,688 principal amount with respect to which the reporting person
exercises sole voting but no investment control, Cerberus International, Ltd.
("International") is the holder of $9,644,090 principal amount of Notes, Ultra
Cerberus, Ltd. ("Ultra") is the holder of $989,137 principal amount of Notes and
certain private investment funds (the "Funds") in the aggregate are the holder
of $7,418,531 principal amount of Notes. The Notes are convertible at the option
of the holder into shares of the Company's Common Stock at the rate of $3.00 per
share, subject to adjustment. Cerberus, International, Ultra and the Funds are
the holders of warrants to purchase, respectively, 76,606, 61,901, 5,771 and
44,109 additional shares of Common Stock of the Company and the reporting person
possesses sole voting but no investment control over warrants to purchase an
additional 2,886 shares of Common Stock of the Company and the shares of Common
Stock of the Company underlying such warrants. Other than as described above,
the reporting person possesses sole voting and investment control of all
securities of the Company owned by each of Cerberus, International, Ultra and
the Funds.
** The reporting person's interest is limited to the extent of his pecuniary
interest in Cerberus, International, Ultra and the Funds, if any.
/s/Stephen Feinberg 7/13/98
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date
Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient. See Instruction 6 for procedure.
